Cell Receptor Specific Targeted Toxins: Genetic Construction and Characterization of an Interleukin 2 Diphtheria Toxin-Related Fusion Protein

References

• Smith K. A. Interleukin 2. Annu. Rev. Immunol. 1984; 2: 319–333
   PubMed Web of Science ®Google Scholar
• Cotner T., Williams J. M., Christenson L., Shapiro H. J., Strom T. B., Strominger J. Simultaneous flow cytometric analysis of human T-cell activation antigen expression and DNA content. J. Exp. Med. 1983; 157: 461–472
   PubMed Web of Science ®Google Scholar
• Williams J. M., Loertscher R., Cotner T., Reddish M., Shapiro H. J., Carpenter C. B., Strominger J., Strom T. B. Dual parametric flow cytometric analysis of DNA content, activation antigen, and T-cell subset proliferation in the human lymphocyte reaction. J. Immunol. 1984; 132: 2330–2337
   Google Scholar
• Robb R. J., Greene W. C., Rusk C. M. Low and high affinity receptors for interleukin-2: implications for the level of Tac antigen. J. Exp. Med. 1984; 160: 1126–1146
   PubMed Web of Science ®Google Scholar
• Lowenthal J. W., Zubler R. H., Nabholz M., MacDonald H. R. Similarities between interleukin-2 receptor number and affinity on activated lymphocyte-T and lymphocyte-B. Nature 1985; 325: 669–672
   Google Scholar
• Fujii M., Sugamura K., Sano K., Naki M., Sagita K., Hinuma Y. High affinity receptor-mediated internalization and degradation of interleukin-2 in human T-cells. J. Exp. Med. 1986; 163: 550–562
   PubMed Web of Science ®Google Scholar
• Weissman A. M., Harford J. B., Svetlik P. B., Leonard W. L., Depper J. M., Waldmann T. A., Greene W. C., Klausner R. D. Only high affinity receptor for interleukin-2 mediate internalization of ligand. Proc. Natl. Acad. Sci. USA 1986; 83: 1463–1466
   PubMed Web of Science ®Google Scholar
• Schreier M. H., Iscover N. N., Tess R., Aarden I., von Boehmer H. Clones of killer and helper T-cells: growth requirements, specificity, and retention of function in long-term culture. Immunol. Rev. 1980; 51: 315–336
   PubMed Web of Science ®Google Scholar
• Farrar J. J., Benjamin W. R., Hilfiker M. L., Howard M., Farrar W. L., Fuller-Farrar J. The biochemistry, biology, and role of interleukin-2 in the induction of cytotoxic T-cell and antibody forming B-cell responses. Immunol. Rev. 1982; 63: 126–166
   Google Scholar
• Maddock E. D., Maddock S. W., Kelley V. E., Strom T. B. Rapid sterospecific stimulation of lymphocytic metabolism by interleukin-2. J. Immunol. 1985; 135: 4004–4008
   Google Scholar
• Waldmann T. A. The interleukin2 receptor on malignant cells: a target for diagnosis and therapy. Cell. Immun. 1986; 99: 53–60
   Google Scholar
• Kirkman R. L., Barrett L. V., Gaulton G. N., Kelley V. E., Ythier A., Strom T. B. Administration of an anti-interleukin-2 receptor monoclonal antibody prolongs allograft survival in mice. J. Exp. Med. 1985; 162: 358–362
   PubMed Web of Science ®Google Scholar
• Kupiec-Weglinski J. W., Diamantstein T., Tilney N. L., Strom T. B. Therapy with monoclonal antibody to interleukin-2 receptor spares suppressor T-cells and prevents or reverses acute allograft rejection. Proc. Natl. Sci. USA 1986; 83: 2624–2627
   Google Scholar
• Kelley V. E., Naor D., Tarcic N., Gaulton G. N., Strom T. B. Anti-interleukin-2 receptor antibody suppresses delayed type hypersensitivity to foreign and syngenic antigens. J. Immunol. 1986; 137: 2122–2124
   Google Scholar
• Kelley V. E., Gaulton G. N., Strom T. B. Inhibitory effects of anti-interleukin2 receptor and anti-L3T4 antibodies on delayed type hypersensitivity: the role of complement and epitope. J. Immunol. 1987, (in press)
   Google Scholar
• Murphy J. R., Bishai W., Borowski M., Miyanohara A., Boyd J., Nagle S. Genetic construction, expression, and melanoma-selective cytotoxicity of a diphtheria toxin-related α-melanocyte stimulating hormone fusion protein. Proc. Natl. Acad. Sci. USA 1986; 83: 8258–8262
   PubMed Web of Science ®Google Scholar
• Maniatis T., Fritsch E. F., Sambrook J. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York 1982
   Google Scholar
• Leong D., Coleman K. D., Murphy J. R. Cloned fragment A of diphtheria toxin is expressed from the tox promoter and exported to the periplasm by the secA apparatus of Escherichia coli K12. J. Biol. Chem. 1983; 258: 15016–15020
   Google Scholar
• Laemmli U. K. Cleavage of structural protein during the assembly of the head of bacteriophage T4. Nature (Lond.) 1970; 227: 680–685
   PubMed Web of Science ®Google Scholar
• Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from acrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 1979; 76: 4350–4354
   PubMed Web of Science ®Google Scholar
• Robb M., Nichols J., Whoriskey S. K., Murphy J. R. Isolation of hybridoma cell lines and characterization of monoclonal antibodies against cholera enterotoxin and its subunits. Infect. Immun. 1982; 38: 267–272
   Google Scholar
• Bishai W. R., Miyanohara A., Murphy J. R. Cloning and expression in Escherichia coli of three fragments of diphtheria toxin truncated within fragment B. J. Bacteriol. 1987, (in press)
   Google Scholar
• Swamy K. H.S., Goldberg A. L. Subcellular distribution of various proteases in Escherichia coli. J. Bacteriol. 1982; 149: 1027–1033
   Google Scholar
• Williams D. P., Parker K., Bishai W., Borowski M., Strom T. B., Murphy J. R. Interleukin-2 receptor targeted cytotoxicity: I. Genetic construction, expression, and purification of a diphtheria toxin-related interleukin2 fusion protein, (submitted for publication)
   Google Scholar
• Bacha P., Williams J., Waters C., Murphy J. R., Strom T. B. Interleukin-2 receptor targeted cytotoxicity: II. Biologic activity of a diphtheria toxin-related interleukin-2 fusion protein, (submitted for publication)
   Google Scholar
• Isberg R. R., Lazaar A. L., Syvanen M. Regulation of Tn5 by the right-repeat proteins: control at the level of the transposition reaction. Cell 1982; 30: 883–892
   Google Scholar
• Varga J. M., Moellmann G. A., Fritsch P., Godawska E., Lerner A. B. Association of cell surface receptors for melanotropin with the golgi region in mouse melanoma cells. Proc. Acad. Sci. USA 1977; 73: 559–562
   Google Scholar
• Vitetta E. S., Krolick K. A., Miyama-Inaba M., Cushley W., Uhr J. Immunotoxins: a new approach to cancer therapy. Science 1983; 219: 644–650
   PubMed Web of Science ®Google Scholar
• Pastan I., Willingham M. C., FitzGerald D. J.P. Immunotoxins. Cell 1986; 47: 641–648
   PubMed Web of Science ®Google Scholar